Literature DB >> 22499732

Causal inference for vaccine effects on infectiousness.

M Elizabeth Halloran1, Michael G Hudgens.   

Abstract

If a vaccine does not protect individuals completely against infection, it could still reduce infectiousness of infected vaccinated individuals to others. Typically, vaccine efficacy for infectiousness is estimated based on contrasts between the transmission risk to susceptible individuals from infected vaccinated individuals compared with that from infected unvaccinated individuals. Such estimates are problematic, however, because they are subject to selection bias and do not have a causal interpretation. Here, we develop causal estimands for vaccine efficacy for infectiousness for four different scenarios of populations of transmission units of size two. These causal estimands incorporate both principal stratification, based on the joint potential infection outcomes under vaccine and control, and interference between individuals within transmission units. In the most general scenario, both individuals can be exposed to infection outside the transmission unit and both can be assigned either vaccine or control. The three other scenarios are special cases of the general scenario where only one individual is exposed outside the transmission unit or can be assigned vaccine. The causal estimands for vaccine efficacy for infectiousness are well defined only within certain principal strata and, in general, are identifiable only with strong unverifiable assumptions. Nonetheless, the observed data do provide some information, and we derive large sample bounds on the causal vaccine efficacy for infectiousness estimands. An example of the type of data observed in a study to estimate vaccine efficacy for infectiousness is analyzed in the causal inference framework we developed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22499732      PMCID: PMC3348179          DOI: 10.2202/1557-4679.1354

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  26 in total

1.  Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries.

Authors:  B Cisse; P Aaby; F Simondon; B Samb; M Soumaré; H Whittle
Journal:  Am J Epidemiol       Date:  1999-02-15       Impact factor: 4.897

2.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

3.  Design of a group-randomized Streptococcus pneumoniae vaccine trial.

Authors:  L H Moulton; K L O'Brien; R Kohberger; I Chang; R Reid; R Weatherholtz; J G Hackell; G R Siber; M Santosham
Journal:  Control Clin Trials       Date:  2001-08

4.  Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus household.

Authors:  S Datta; M E Halloran; I M Longini
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

Review 5.  Assessing vaccine efficacy in the field. Further observations.

Authors:  W A Orenstein; R H Bernier; A R Hinman
Journal:  Epidemiol Rev       Date:  1988       Impact factor: 6.222

6.  Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness.

Authors:  Marie-Pierre Préziosi; M Elizabeth Halloran
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

7.  A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines.

Authors:  I M Longini; M G Hudgens; M E Halloran; K Sagatelian
Journal:  Stat Med       Date:  1999-01-15       Impact factor: 2.373

8.  Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.

Authors:  Eugene V Millar; James P Watt; Melinda A Bronsdon; Jean Dallas; Raymond Reid; Mathuram Santosham; Katherine L O'Brien
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

9.  Field trial of oral cholera vaccines in Bangladesh.

Authors:  J D Clemens; D A Sack; J R Harris; J Chakraborty; M R Khan; B F Stanton; B A Kay; M U Khan; M Yunus; W Atkinson
Journal:  Lancet       Date:  1986-07-19       Impact factor: 79.321

10.  Assessing HIV vaccine effects.

Authors:  J S Koopman; R J Little
Journal:  Am J Epidemiol       Date:  1995-11-15       Impact factor: 4.897

View more
  9 in total

1.  Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects.

Authors:  Tyler J Vanderweele; Eric J Tchetgen Tchetgen; M Elizabeth Halloran
Journal:  Epidemiology       Date:  2012-09       Impact factor: 4.822

2.  On inverse probability-weighted estimators in the presence of interference.

Authors:  L Liu; M G Hudgens; S Becker-Dreps
Journal:  Biometrika       Date:  2016-12-08       Impact factor: 2.445

3.  Interference and Sensitivity Analysis.

Authors:  Tyler J VanderWeele; Eric J Tchetgen Tchetgen; M Elizabeth Halloran
Journal:  Stat Sci       Date:  2014-11       Impact factor: 2.901

4.  Dependent Happenings: A Recent Methodological Review.

Authors:  M Elizabeth Halloran; Michael G Hudgens
Journal:  Curr Epidemiol Rep       Date:  2016-07-28

5.  Causal Inference Under Multiple Versions of Treatment.

Authors:  Tyler J VanderWeele; Miguel A Hernán
Journal:  J Causal Inference       Date:  2013-05-01

6.  Assessing intervention effects in a randomized trial within a social network.

Authors:  Shaina J Alexandria; Michael G Hudgens; Allison E Aiello
Journal:  Biometrics       Date:  2021-11-26       Impact factor: 1.701

7.  Comparing bounds for vaccine effects on infectiousness.

Authors:  M Elizabeth Halloran; Michael G Hudgens
Journal:  Epidemiology       Date:  2012-11       Impact factor: 4.822

8.  The Minicommunity Design to Assess Indirect Effects of Vaccination.

Authors:  M Elizabeth Halloran
Journal:  Epidemiol Methods       Date:  2012-08-01

9.  Spillover effects in epidemiology: parameters, study designs and methodological considerations.

Authors:  Jade Benjamin-Chung; Benjamin F Arnold; David Berger; Stephen P Luby; Edward Miguel; John M Colford; Alan E Hubbard
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.